查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1817410

脊椎穿刺針的全球市場::各類型，各用途，各終端用戶，各地區，2027年預測

Global Spinal Needles Market Research Report Information by Type, by Application, by End User, and by Region Forecast till 2027
出版日期: | 出版商: Market Research Future | 英文 114 Pages | 訂單完成後即時交付

價格

產業概要

全球脊椎穿刺針市場預計將以7.48%的複合年增長率成長，到2027年底將達到3.5674億美元。脊椎穿刺針是一種細長空心的裝置，用於穿透脊椎管進行麻醉或腦脊髓液抽取。其鋒利精準的針尖確保了精細操作的精確度，同時降低了受傷風險。其常見應用包括腰椎穿刺、脊椎麻醉和某些治療介入。

推動全球市場發展的關鍵因素之一是符合人體工學的脊椎關節在疼痛管理、椎體成形術、椎體後凸成形術和脊椎融合術等治療手術中的應用日益增多。由於其卓越的安全性和有效性，外科醫生越來越青睞使用鉛筆尖穿刺針進行麻醉，推動了其應用的不斷增加。脊椎穿刺針的設計、各種臨床試驗以及政府對研究的投入都在不斷進步。脊椎器械的預測市場可能會受到該領域從開放性手術到微創手術的最新趨勢的強烈影響。

公司主要發展

美敦力公司持續穩定地加強其在脊椎外科領域的全球影響力。尤其值得一提的是，美敦力於2020年11月收購了法國Medicrea公司，這使得美敦力能夠將基於人工智慧的尖端技術應用於手術計畫、植入物和機器人技術，成為首家在該領域提供此類解決方案的公司。收購專注於脊椎植入物表面技術的美國公司Titan Spine，為美敦力提供了新的技術和專業知識資源，鞏固了其作為脊椎植入物領先製造商的地位。透過這些舉措，美敦力彰顯了對技術創新、企業擴張和脊椎相關醫療保健進步的承諾。

主要參與者

全球脊椎穿刺針市場的主要參與者包括史賽克 (Stryker)、波士頓科學公司 (Boston Scientific Corporation)、貝朗梅爾松根公司 (B. Braun Melsungen AG)、美敦力公司 (Medtronic Plc)、史密斯醫療 (Smiths Medical)、碧迪公司 (Becton, Dickinson, and

報告屬性詳情

  • 2020 年市場規模：2.1642 億美元
  • 2027 年市場規模：3.5674 億美元
  • 複合年增長率 (2021-2027)：7.48%
  • 基準年：2020 年
  • 市場預測期：2021-2027 年

按行業細分

  • 依類型：非侵入性針：7.33%，定向脊椎針：6.52%
  • 依應用：治療 - 7.87%，診斷 - 6.61%
  • 最終使用者：醫院和診所 - 8.39%，診斷中心 - 7.54%

地區分析

美洲地區脊椎穿刺針的使用量顯著增加，主要原因是退化性脊椎和神經系統疾病的發生率不斷上升。美國仍然是最大的貢獻者，每年新增數千例，而脊椎和腦腫瘤的發生率不斷上升，促使對腰椎穿刺等診斷服務的需求增加。由於脊椎疾病發生率高且醫療器材普及，北美地區仍是最大的市場，2020 年市場規模達 6,754 萬美元。拉丁美洲的市場規模為 2054 萬美元，並且隨著人們對脊椎診斷服務的認識和需求而不斷增長。

歐洲脊椎穿刺針市場的主要驅動力是該大陸人口老化，這使得該地區患有神經退化性疾病的風險更高。根據歐盟統計局的數據，未來 65 歲及以上人口將大幅成長，這將推動對脊椎診斷和治療的需求成長。西歐佔4,253萬美元，東歐佔1,468萬美元，展現出成熟市場和新興市場的混合。

亞太地區的成長勢頭迅猛，主要得益於對先進醫療服務的巨大需求以及不斷擴大的研究活動。中國和印度不斷增加對醫療基礎設施的投資，不僅使其成為該地區最大的市場，也提高了醫療服務的可近性。在醫療保健進步的推動下，亞太地區正在迅速擴張，其中中國佔998萬美元，印度佔825萬美元，日本佔709萬美元。

雖然中東和非洲的市場佔有率較小，但對醫療設施投資的增加帶來了越來越多的機會。基礎設施的改善和醫療支出的增加正在推動中東國家對醫療服務的採用。與國際醫療器材公司的合作正在改善非洲地區脊椎穿刺針的可及性。

目錄

第1章 摘要整理

第2章 市場簡介

第3章 調查手法

第4章 市場動態

  • 概要
  • 促進因素
    • 脊椎狹窄和神經系統疾病盛行率不斷上升
    • 老年人口日益易患脊椎疾病
    • 脊椎穿刺針在脊椎手術的使用日益增多
  • 阻礙因素
    • 脊椎手術相關的副作用和併發症
    • 嚴格的政府法規
  • 機遇
    • 不斷增加的合作、收購和產品發布

第5章 市場要素分析

  • 價值鏈分析
  • 波特的五力分析
  • COVID-19影響分析

第6章 全球脊椎穿刺針市場(各類型)

  • 簡介
  • 非侵入性脊椎穿刺針
  • 定向脊椎穿刺針
  • 鉛筆尖穿刺針

第7章 全球脊椎穿刺針市場(各用途)

  • 簡介
  • 治療
  • 診斷

第8章 脊椎穿刺針市場(各終端用戶)

  • 概要
  • 醫院·診所
  • 診斷中心
  • 調查室
  • 專門中心

第9章 全球脊椎穿刺針市場(各地區)

  • 概要
  • 南北美洲
    • 北美
    • 南美
  • 歐洲
    • 西歐
    • 東歐
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 其他
  • 中東·非洲
    • 中東
    • 非洲

第10章 競爭情形

  • 概要
  • 競爭基準
  • 全球脊椎穿刺針市場上主要成長策略
  • 全球脊椎穿刺針開發數的主要企業
  • 主要的開發分析
  • 主要的發展與成長策略
  • 財務矩陣

第11章 企業簡介

  • STRYKER CORPORATION
  • BOSTON SCIENTIFIC CORPORATION
  • B. BRAUN MELSUNGEN AG
  • MEDTRONIC PLC
  • SMITHS MEDICAL
  • BECTON, DICKINSON, AND COMPANY
  • EXELINT INTERNATIONAL, CO.
  • ARGON MEDICAL
  • MYCO MEDICAL
  • COOK MEDICAL

第12章 附錄

Product Code: MRFR/MED/0709-HCR

Global Spinal Needles Market Research Report Information by Type (Atraumatic Needles, Directional Spinal Needles, Pencil-point Needles), by Application (Therapeutic, Diagnostic), by End User (Hospitals & Clinics, Diagnostic Centers, Research Laboratories, Specialty Centers), and by Region (Americas, Europe, Asia Pacific, Middle East and Africa) Forecast till 2027

Industry Overview

The global spinal needles market is expected to be valued at USD 356.74 million with a CAGR of 7.48% by the end of 2027. A spinal needle is a thin, hollow device designed to puncture the spinal canal for administering anesthesia or withdrawing cerebrospinal fluid. Its sharp, precise tip ensures accuracy during delicate procedures while reducing the risk of injury. Common uses include lumbar punctures, spinal anesthesia, and certain therapeutic interventions.

One of the main factors for this worldwide market development is the growth in ergonomic use of the spinal joints in therapeutic procedures, such as pain management, vertebroplasty, kyphoplasty, and spinal fusion. Surgeons increasingly favor pencil-point needles for anesthesia due to superior safety and effectiveness, driving higher adoption. There is constant progress in spinal needle design, various clinical trials, and the government, which is stepping up research investments. The predicted market for spinal directing devices is going to be strongly affected by this recent development of the sector, from open surgeries to minimally invasive surgeries.

Major Company Development

Medtronic plc is still working steadily to strengthen its presence worldwide in spinal surgery through its achievements. Among others, by acquiring Medicrea in France in November 2020, Medtronic has allowed itself to adopt cutting-edge AI-driven technologies for surgical planning, as well as implants and robotics, making it the first company to launch such solutions in the sector. The takeover of Titan Spine, an American company specializing in spinal implant surface technologies, gave the company new resources for technology and expertise and strengthened its position as the leading spinal implant manufacturer. Through these movements, Medtronic sends a message of its focus on technological innovation, company expansion, and the upgrading of healthcare related to the spine.

Key Players

Major players in the global spinal needles market are Stryker, Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic Plc, Smiths Medical, Becton, Dickinson, and Company, EXELINT International, Co., Argon Medical, Myco Medical, and Cook Medical.

Report Attribute Details

  • Market Size 2020: USD 216.42 Million
  • Market Size 2027: USD 356.74 Million
  • CAGR (2021-2027): 7.48%
  • Base Year: 2020
  • Market Forecast Period: 2021-2027

Industry Segmentations

  • By Type: Atraumatic Needles - 7.33%, Directional Spinal Needles - 6.52%.
  • By Application: Therapeutic - 7.87%, Diagnostic - 6.61%.
  • By End User: Hospitals & Clinics - 8.39%, Diagnostic Centers - 7.54%.

Regional Analysis

The adoption of spinal needles in the Americas is going up significantly, and the main factor for this trend is the increasing incidence of degenerative spinal and neurological diseases. The U.S. is still the biggest contributor, with the occurrence of spinal and brain cancers every year that lead to the necessity of diagnostic services like lumbar punctures, in which thousands of new cases are registered annually. Valued at USD 67.54 million in 2020, North America remains the largest market due to high incidences of spinal disorders and the broad availability of medical devices. The market in Latin America, worth USD 20.54 million, is growing as awareness and demand for spinal diagnostic services increase.

The spinal needles market in Europe is mainly supported by the continent's aging population, which has a higher risk of neurodegenerative diseases. According to Eurostat, the demographic of people aged 65 and above is going to increase drastically, and this is going to be translated into a greater need for spinal diagnostics and treatments. Western Europe generated USD 42.53 million, while Eastern Europe contributed USD 14.68 million, underscoring a mix of mature markets and emerging opportunities.

The growth of Asia-Pacific is absolutely incomparable, and the main reasons for this are the huge demand for sophisticated healthcare services and the broadened research activities. Rising investments in healthcare infrastructure in both China and India not only fuel the two countries to become the region's largest markets but also elevate accessibility. With China at USD 9.98 million, India at USD 8.25 million, and Japan at USD 7.09 million, APAC is seeing rapid uptake fueled by healthcare advancements.

Middle East & Africa hold a smaller market share, opportunities are growing with increased investments in healthcare facilities. Countries in the Middle East are witnessing rising adoption due to improving infrastructure and greater healthcare expenditure. In Africa, partnerships with international medical device companies have improved access to spinal needles.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY
  • 2.2 RESEARCH OBJECTIVE
  • 2.3 MARKET STRUCTURE
  • 2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING PREVALENCE OF SPINAL STENOSIS AND NEUROLOGICAL DISORDERS
    • 4.2.2 RISING GERIATRIC POPULATION PRONE TO SPINAL DISORDERS
    • 4.2.3 INCREASING APPLICATION OF SPINAL NEEDLES FOR SPINE SURGERIES
  • 4.3 RESTRAINTS
    • 4.3.1 SIDE EFFECTS AND COMPLICATIONS ASSOCIATED WITH SPINE SURGERY
    • 4.3.2 STRINGENT GOVERNMENT REGULATIONS
  • 4.4 OPPORTUNITIES
    • 4.4.1 INCREASING NUMBER OF COLLABORATIONS, ACQUISITIONS, AND PRODUCT LAUNCHES

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D AND DESIGNING
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION, MARKETING, & SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 COVID-19 IMPACT ANALYSIS
    • 5.3.1 IMPACT ON SPINAL SURGERY
    • 5.3.2 IMPACT ON SPINE SURGEONS
    • 5.3.3 IMPACT ON CLINICAL TRIALS

6 GLOAL SPINAL NEEDLES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 ATRAUMATIC NEEDLES
  • 6.3 DIRECTIONAL SPINAL NEEDLES
  • 6.4 PENCIL-POINT NEEDLES

7 GLOBAL SPINAL NEEDLES MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 THERAPEUTIC
  • 7.3 DIAGNOSTIC

8 SPINAL NEEDLES MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS & CLINICS
  • 8.3 DIAGNOSTIC CENTERS
  • 8.4 RESEARCH LABORATORIES
  • 8.5 SPECIALTY CENTERS

9 GLOBAL SPINAL NEEDLES MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 AMERICAS
    • 9.2.1 NORTH AMERICA
      • 9.2.1.1 US
      • 9.2.1.2 CANADA
    • 9.2.2 LATIN AMERICA
  • 9.3 EUROPE
    • 9.3.1 WESTERN EUROPE
      • 9.3.1.1 GERMANY
      • 9.3.1.2 FRANCE
      • 9.3.1.3 UK
      • 9.3.1.4 ITALY
      • 9.3.1.5 SPAIN
      • 9.3.1.6 REST OF WESTERN EUROPE
    • 9.3.2 EASTERN EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 INDIA
    • 9.4.3 JAPAN
    • 9.4.4 SOUTH KOREA
    • 9.4.5 AUSTRALIA
    • 9.4.6 REST OF ASIA PACIFIC
  • 9.5 MIDDLE EAST & AFRICA
    • 9.5.1 MIDDLE EAST
    • 9.5.2 AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 COMPETITIVE BENCHMARKING
  • 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL SPINAL NEEDLES MARKET
  • 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL SPINAL NEEDLES

MARKET 80

  • 10.5 KEY DEVELOPMENT ANALYSIS
  • 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
    • 10.6.2 MERGER/ACQUISITION
    • 10.6.3 EXPANSION/INVESTMENT
  • 10.7 FINANCIAL MATRIX
    • 10.7.1 SALES (USD MILLION) AND OPERATING PROFIT MARGIN (%), 2020
    • 10.7.2 R&D EXPENDITURE (USD MILLION), 2020

11 COMPANY PROFILES

  • 11.1 STRYKER CORPORATION
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 BOSTON SCIENTIFIC CORPORATION
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS/SERVICES OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 B. BRAUN MELSUNGEN AG
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS/SERVICES OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 MEDTRONIC PLC
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS/SERVICES OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGIES
  • 11.5 SMITHS MEDICAL
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS/SERVICES OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 BECTON, DICKINSON, AND COMPANY
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 SWOT ANALYSIS
    • 11.6.6 KEY STRATEGIES
  • 11.7 EXELINT INTERNATIONAL, CO.
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGIES
  • 11.8 ARGON MEDICAL
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 MYCO MEDICAL
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 COOK MEDICAL
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 SWOT ANALYSIS
    • 11.10.6 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 4 GLOBAL: SPINAL NEEDLES MARKET, FOR ATRAUMATIC NEEDLES, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 5 GLOBAL: SPINAL NEEDLES MARKET, FOR DIRECTIONAL SPINAL NEEDLES, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 6 GLOBAL: SPINAL NEEDLES MARKET, FOR PENCIL-POINT NEEDLES, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 7 GLOBAL: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 8 GLOBAL: SPINAL NEEDLES MARKET, FOR THERAPEUTIC, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 9 GLOBAL: SPINAL NEEDLES MARKET, FOR DIAGNOSTIC, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 10 GLOBAL: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 11 GLOBAL: SPINAL NEEDLES MARKET, FOR HOSPITALS & CLINICS, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 12 GLOBAL: SPINAL NEEDLES MARKET, FOR DIAGNOSTICS CENTERS, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 13 GLOBAL: SPINAL NEEDLES MARKET, FOR RESEARCH LABORTORIES, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 14 GLOBAL: SPINAL NEEDLES MARKET, FOR SPECIALITY CENTERS, BY REGIONS, 2018-2027 (USD MILLION)
  • TABLE 15 GLOBAL: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16 AMERICAS: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 AMERICAS: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 18 AMERICAS: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 19 AMERICAS: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 20 NORTH AMERICA: SPINAL NEEDLES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 21 NORTH AMERICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 22 NORTH AMERICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 23 NORTH AMERICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 24 US: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 25 US: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 26 US: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 27 CANADA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 28 CANADA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 29 CANADA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 30 LATIN AMERICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 31 LATIN AMERICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 32 LATIN AMERICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 33 EUROPE: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 34 EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 35 EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 36 EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 37 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 38 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 39 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 40 WESTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 41 GERMANY: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 42 GERMANY: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 43 GERMANY: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 44 FRANCE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 45 FRANCE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 46 FRANCE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 47 UK: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 48 UK: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 49 UK: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 50 ITALY: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 51 ITALY: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 52 ITALY: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 53 SPAIN: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 54 SPAIN: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 55 SPAIN: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 56 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 57 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 58 REST OF WESTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 59 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 60 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 61 EASTERN EUROPE: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 66 CHINA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 67 CHINA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 68 CHINA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 69 INDIA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 70 INDIA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 71 INDIA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 72 JAPAN: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 73 JAPAN: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 74 JAPAN: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 75 SOUTH KOREA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 76 SOUTH KOREA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 77 SOUTH KOREA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 78 AUSTRALIA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 79 AUSTRALIA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 80 AUSTRALIA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 81 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 82 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 83 REST OF ASIA PACIFIC: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 84 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 85 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 86 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 87 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 88 MIDDLE EAST: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 89 MIDDLE EAST: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 90 MIDDLE EAST: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 91 AFRICA: SPINAL NEEDLES MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 92 AFRICA: SPINAL NEEDLES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 93 AFRICA: SPINAL NEEDLES MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 94 MAJOR PLAYERS IN THE GLOBAL SPINAL NEEDLES MARKET
  • TABLE 95 MOST ACTIVE PLAYER IN THE GLOBAL SPINAL NEEDLES MARKET
  • TABLE 96 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 97 MERGER/ACQUISITION
  • TABLE 98 EXPANSION/INVESTMENT
  • TABLE 99 STRYKER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 100 STRYKER CORPORATION: KEY DEVELOPMENTS
  • TABLE 101 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 102 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS
  • TABLE 103 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED
  • TABLE 104 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENTS
  • TABLE 105 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED
  • TABLE 106 MEDTRONIC PLC: KEY DEVELOPMENTS
  • TABLE 107 SMITHS MEDICAL: PRODUCTS/SERVICES OFFERED
  • TABLE 108 SMITHS MEDICAL: KEY DEVELOPMENTS
  • TABLE 109 BECTON, DICKINSON, AND COMPANY: PRODUCTS/SERVICES OFFERED
  • TABLE 110 BECTON, DICKINSON, AND COMPANY: KEY DEVELOPMENTS
  • TABLE 111 EXELINT INTERNATIONAL, CO.: PRODUCTS/SERVICES OFFERED
  • TABLE 112 ARGON MEDICAL: PRODUCTS/SERVICES OFFERED
  • TABLE 113 ARGON MEDICAL: KEY DEVELOPMENTS
  • TABLE 114 MYCO MEDICAL: PRODUCTS/SERVICES OFFERED
  • TABLE 115 COOK MEDICAL: PRODUCTS/SERVICES OFFERED
  • TABLE 116 COOK MEDICAL: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL SPINAL NEEDLES MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: GLOBAL SPINAL NEEDLES MARKET
  • FIGURE 5 DRIVERS: IMPACT ANALYSIS
  • FIGURE 6 RESTRAINTS: IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS OF GLOBAL SPINAL NEEDLES MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL SPINAL NEEDLES MARKET
  • FIGURE 9 GLOBAL SPINAL NEEDLES MARKET, BY TYPE, 2020 & 2027 (USD MILLION)
  • FIGURE 10 GLOBAL SPINAL NEEDLES MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION)
  • FIGURE 11 GLOBAL SPINAL NEEDLES MARKET, BY END USER, 2020 & 2027 (USD MILLION)
  • FIGURE 12 GLOBAL: SPINAL NEEDLES MARKET, BY REGION 2020 & 2027 (USD MILLION)
  • FIGURE 13 GLOBAL: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020
  • FIGURE 14 AMERICAS: SPINAL NEEDLES MARKET SHARE (%), BY REGION 2020
  • FIGURE 15 NORTH AMERICA: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY 2020
  • FIGURE 16 EUROPE: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020
  • FIGURE 17 WESTERN EUROPE: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY, 2020
  • FIGURE 18 ASIA PACIFIC: SPINAL NEEDLES MARKET SHARE (%), BY COUNTRY 2020
  • FIGURE 19 MIDDLE EAST & AFRICA: SPINAL NEEDLES MARKET SHARE (%), BY REGION, 2020
  • FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL SPINAL NEEDLES MARKET
  • FIGURE 22 GLOBAL SPINAL NEEDLES MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 23 SALES (USD MILLION) AND OPERATING PROFIT MARGIN (%), 2020
  • FIGURE 24 R&D EXPENDITURE (USD MILLION), 2020
  • FIGURE 25 STRYKER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 26 STRYKER CORPORATION: SWOT ANALYSIS
  • FIGURE 27 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 28 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
  • FIGURE 29 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 30 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
  • FIGURE 31 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 32 B MEDTRONIC PLC: SWOT ANALYSIS
  • FIGURE 33 SMITHS GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 34 SMITHS MEDICAL: SWOT ANALYSIS
  • FIGURE 35 BECTON, DICKINSON, AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 36 BECTON, DICKINSON, AND COMPANY: SWOT ANALYSIS
  • FIGURE 37 EXELINT INTERNATIONAL, CO.: SWOT ANALYSIS
  • FIGURE 38 ARGON MEDICAL: SWOT ANALYSIS
  • FIGURE 39 MYCO MEDICAL: SWOT ANALYSIS
  • FIGURE 40 COOK MEDICAL: SWOT ANALYSIS